While 2023 net revenue was 26% lower than that peak, as interest rates and economic uncertainty increased, the firm appears to have stabilized and looks poised for a return to high-single-digit ...

Investing.com -- Evercore ISI added Wendy’s Co to its Tactical Outperform list ahead of the company’s investor day on March 6 ...

Shares of Vera Therapeutics (VERA) sold off about 20% on Friday following news in competitor Otsuka’s 2024 earnings presentation that the ...

Specialty MGA Optio Group has retained investment bank Evercore with a mandate to explore its debt options, as the business ...

Evercore ISI analyst Stephen Richardson maintained a Buy rating on Conocophillips (COP – Research Report) on February 14 and set a price target ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Evercore ISI analysts upgraded CRISPR Therapeutics stock from an In Line to an Outperform rating and increased the price target significantly to $99 from the previous $60. The upgrade comes as ...

Walgreens Boots Alliance Inc. is getting advice from Perella Weinberg Partners and AlixPartners for help with its operations ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Riot Platforms is expanding into AI and high-performance computing partnerships while adding three new board members with ...